Sameera Peraramelli
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.
Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.
Journal: Frontiers in immunology
Published: January 12, 2024
Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 13, 2023
Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 02, 2021
Role of exosite binding modulators in the inhibition of Fxa by TFPI.
Journal: Thrombosis and haemostasis
Published: April 29, 2015
Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 04, 2014
Direct inhibition of factor VIIa by TFPI and TFPI constructs.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 12, 2012
The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
Journal: Thrombosis and haemostasis
Published: January 02, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026